What's in Abbott Medical Devices's pipeline?

Abbott Medical Devices has 2 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 1 in Phase 1.

Which companies overlap with Abbott Medical Devices's portfolio?

Top competitors by shared drug class: Beijing Tiantan Hospital.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/abbott-medical-devices.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Abbott Medical Devices — Portfolio Competitive Intelligence Brief

Abbott Medical Devices pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
clopidogrel + aspirin OR prasugrel + aspirin	clopidogrel + aspirin OR prasugrel + aspirin	marketed	Dual antiplatelet therapy (DAPT)	P2Y12 receptor (clopidogrel/prasugrel) and cyclooxygenase (aspirin)	Cardiovascular

Therapeutic area mix

Cardiovascular · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Beijing Tiantan Hospital · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Abbott Medical Devices:

Cite this brief

Drug Landscape (2026). Abbott Medical Devices — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/abbott-medical-devices. Accessed 2026-05-16.